Exodus Point Capital Management, LP Adicet Bio, Inc. Transaction History

Exodus Point Capital Management, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	BUY	$5.52 - $9.23 $128,571 - $214,985	23,292 New	23,292 $134,000
Q2 2021 Aug 16, 2021	SELL	$9.19 - $15.93 $658,803 - $1.14 Million	-71,687 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$12.12 - $17.17 $294,103 - $416,647	24,266 Added 51.17%	71,687 $938,000
Q4 2020 Feb 16, 2021	BUY	$10.36 - $14.77 $491,281 - $700,408	47,421 New	47,421 $666,000

59.2M

4.2K

6.7K

Ticker ACET
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,030,800
Market Cap $39.6M
Description
Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.